查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030024

臨床營養市場－全球產業規模、佔有率、趨勢、機會、預測：按給藥途徑、營養類型、應用、最終用戶、基材、地區和競爭格局分類，2021-2031年

Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration, By Nutrition Type, By Application, By End User, By Substrates, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球臨床營養市場預計將從 2025 年的 340.9 億美元成長到 2031 年的 483.8 億美元，複合年成長率為 6.01%。

該市場涵蓋為因疾病、傷害或其他健康問題而無法透過常規飲食滿足營養需求的人群提供的專業營養服務和產品。推動此領域成長的因素包括：全球慢性病盛行率不斷上升、需要營養照護的老年人口日益成長，以及醫療保健專業人員對營養在改善患者復原方面重要性的認知不斷提高。為了反映這種全球關注度，根據歐洲臨床營養與代謝學會 (ESPEN) 統計，2025 年舉辦的​​第 47 屆 ESPEN 臨床營養與代謝大會吸引了超過 4700 名國際參與者。

市場概覽
預測期 2027-2031
市場規模：2025年 340.9億美元
市場規模：2031年 483.8億美元
複合年成長率：2026-2031年 6.01%
成長最快的細分市場 經腸營養
最大的市場 北美洲

營養處方創新和居家營養療法的日益普及也推動了市場成長。然而，專業臨床營養產品的高昂成本及其複雜的給藥方式是阻礙市場進一步發展的主要障礙。這限制了其成本效益，也影響了其在全球不同醫療保健系統中的可近性。

市場促進因素

全球臨床營養市場的主要驅動力是全球慢性病盛行率的不斷上升。癌症、糖尿病和胃腸道疾病等疾病常常導致正常飲食攝取困難、代謝需求增加或吸收不良，因此需要專業的營養支持。隨著這些健康挑戰對醫療保健系統造成額外負擔，臨床營養對於患者復健、疾病管理和提高生活品質的重要性日益凸顯。美國心臟協會於2026年3月發布的一份資訊圖表強調了這個問題，該資訊圖表基於2024年的數據，顯示美國有2930萬成年人患有糖尿病，這種疾病通常需要特殊的營養產品和飲食計劃來控制血糖值並預防併發症。因此，針對特定疾病的客製化營養解決方案的需求不斷推動著市場成長和創新。

人口老化也是市場成長的促進因素之一，因為老年人極易患上與老齡化相關的慢性疾病、肌少症和營養不良。隨著老齡化，生理變化、食慾下降以及需要服用多種藥物都會使飲食需求變得複雜，因此臨床營養對於維持獨立生活和整體健康至關重要。這些人口結構變化正在加速對專為老年人配製的、營養豐富且易於消化的產品的需求。為了佐證這一強勁的需求，達能在2026年2月報告稱，其醫療營養部門2025年的年銷售額將超過10億歐元。最終，這些健康和人口趨勢共同推動了市場的持續擴張。雀巢健康科學部門2025年的銷售額累計66億瑞士法郎，也印證了這一點。

市場挑戰

全球臨床營養市場擴張面臨的主要障礙之一是專業營養產品的高成本，以及其給藥流程的複雜性。這些問題直接阻礙了全球各醫療保健系統提供價格合理的營養產品並保障患者取得這些產品。這些基本治療的高昂費用常常給公共和私人醫療保健預算帶來巨大壓力，導致保險覆蓋範圍有限和醫療發行。因此，許多需要營養支持的患者無法獲得治療，尤其是在自付費用高或醫療基礎設施落後的地區。

儘管臨床療效已得到證實，但初始資金投入仍是一大障礙。根據美國營養與飲食學會2025年11月發布的報告，醫學營養療法透過改善健康結果，每年可為每位患者降低成本。然而，高昂的初始成本以及通常需要特定設備和訓練有素的人員的複雜治療方式，仍然是患者獲得治療的主要障礙。最終，這限制了臨床營養服務市場擴張和成長的潛力，因為許多保險公司和醫療機構優先考慮的是短期成本而非長期經濟效益。

市場趨勢

推動全球臨床營養市場發展的關鍵趨勢之一是向個人化營養治療的轉變。這種策略摒棄了千篇一律的標準化建議，而是根據每位患者的個別特徵最佳化治療方案，包括特定的代謝需求、腸道菌群組成和遺傳傾向。透過提供與患者獨特生理需求完美匹配的營養素，這種客製化方法旨在最大限度地減少副作用，並提高治療成功率。為了彰顯產業對這些先進解決方案的承諾，雀巢公司於2026年2月19日發布新聞稿宣布，計劃在2026年追加投資6億瑞士法郎，以拓展其成長舉措，包括其營養與健康科學部門。

消費者對植物來源臨床營養日益成長的興趣是推動醫學營養領域變革的另一個主要趨勢。在對飲食習慣、倫理價值觀和食物過敏有了更深入的了解之後，醫護人員和患者都在積極尋求素食和純素食的醫學營養替代方案。這種需求促使生產商開發利用植物來源微量營養素和替代蛋白的新產品，使更多患者能夠獲得專業的營養護理。雀巢公司於2026年3月推出了「Complete Pediatric Oral Blends」系列產品，展現了對這一趨勢的承諾。此系列產品富含植物蛋白，以水果為基礎。該產品最初在幾個歐洲國家推出，清楚地表明了該行業正在積極適應日益成長的植物來源臨床營養需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球臨床營養市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 給藥途徑（口服、靜脈注射）
    • 營養類型（經腸營養、腸外營養）
    • 按應用領域（代謝紊亂、飲食障礙、發育和恢復階段、其他）
    • 依最終使用者（嬰兒、成人、老年人）分類
    • 依成分分類（能量、碳水化合物、脂類、蛋白質/胺基酸、水/電解質、膳食纖維、抗氧化劑）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲臨床營養市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球臨床營養市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories
  • Nestle Health Science
  • Danone SA
  • Fresenius Kabi AG
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Pfizer Inc.
  • Perrigo Company plc
  • Mead Johnson Nutrition Company
  • Hero Nutritionals Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 4664

The Global Clinical Nutrition Market is anticipated to expand from USD 34.09 billion in 2025 to USD 48.38 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.01%. This market involves specialized nutritional services and products designed for people who cannot fulfill their dietary needs through regular food due to medical conditions, injuries, or illnesses. The sector's growth is fueled by the rising worldwide rate of chronic illnesses, a growing elderly demographic in need of nutritional care, and increased recognition among medical experts of the importance of nutrition in improving patient recovery. Highlighting this global interest, the 47th ESPEN Congress on Clinical Nutrition and Metabolism in 2025 hosted over 4,700 international attendees, according to the European Society for Clinical Nutrition and Metabolism.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 34.09 Billion
Market Size 2031USD 48.38 Billion
CAGR 2026-20316.01%
Fastest Growing SegmentEnteral Nutrition
Largest MarketNorth America

Market growth is also stimulated by innovations in nutritional formulas and the wider availability of at-home nutritional treatments. Nevertheless, a major obstacle hindering further market development is the steep expense of specialized clinical nutrition items combined with the complexity of their administration, which restricts both affordability and access across various healthcare systems around the world.

Market Driver

The Global Clinical Nutrition Market is largely driven by the rising incidence of chronic illnesses globally. Diseases like cancer, diabetes, and gastrointestinal issues frequently cause challenges with standard food consumption, heightened metabolic needs, or poor nutrient absorption, creating a need for dedicated nutritional assistance. As these health challenges place a heavier strain on medical systems, clinical nutrition becomes increasingly vital for enhancing patient recovery, management, and quality of life. Highlighting this issue, a March 2026 infographic of 2024 data from the American Heart Association revealed that 29.3 million US adults had diabetes, an illness that often demands specialized nutritional products and dietary plans to control blood sugar and avoid complications. Consequently, the need for customized nutritional solutions tailored to specific diseases continuously spurs market growth and innovation.

The expanding elderly population serves as another crucial market driver, as older adults are highly vulnerable to age-related chronic diseases, sarcopenia, and malnutrition. Aging brings physiological changes, decreased appetite, and the use of multiple medications, all of which complicate dietary needs and make clinical nutrition vital for preserving independence and overall well-being. This shift in demographics accelerates the need for nutrient-rich, easy-to-consume products formulated specifically for seniors. Demonstrating this high demand, Danone S.A. reported in February 2026 that its medical nutrition division exceeded €1 billion in 2025 annual revenue. Ultimately, these combined health and demographic trends strongly support the market's ongoing expansion, as evidenced by Nestle S.A.'s Health Science division generating CHF 6.6 billion in revenue during 2025.

Market Challenge

A major hurdle limiting the expansion of the Global Clinical Nutrition Market is the steep expense of specialized nutritional products, coupled with the complicated procedures required to administer them. These issues directly hinder affordability and access within various healthcare systems around the world. Because these essential therapies demand a significant financial commitment, they frequently overwhelm public and private medical budgets, leading to limited insurance coverage or rationed care. As a result, numerous patients needing nutritional aid go without it, especially in areas characterized by high out-of-pocket costs or underdeveloped medical infrastructures.

Even with established clinical benefits, the initial financial investment poses a persistent obstacle. A November 2025 report from the Academy of Nutrition and Dietetics indicated that medical nutrition therapy actually saves between $638 and $1,450 annually per patient by enhancing health outcomes. Nevertheless, the high upfront costs and complicated delivery methods, which frequently require specific equipment and trained personnel, still generate major barriers to patient access. Ultimately, this restricts the broader market reach and growth potential of clinical nutrition services, since many insurance payers and healthcare providers focus on the immediate expenses rather than the long-term financial benefits.

Market Trends

A key trend strongly shaping the Global Clinical Nutrition Market is the growing shift toward personalized nutritional therapies. Moving away from standard, one-size-fits-all advice, this strategy tailors targeted treatments to individual patient characteristics, such as specific metabolic demands, microbiome makeup, and genetic tendencies. By supplying nutrients that perfectly match a patient's distinct physical needs, this customized method seeks to minimize negative side effects and maximize treatment success. Highlighting the industry's dedication to these sophisticated solutions, Nestle S.A. revealed in a February 19, 2026 press release that it plans an extra CHF 0.6 billion investment in 2026 to broaden its growth initiatives, encompassing its Nutrition and Health Science branch.

The rising consumer interest in plant-based clinical nutrition is another major trend transforming the medical nutrition sector. Motivated by dietary habits, ethical values, and a greater understanding of food allergies, both medical professionals and patients are actively looking for vegetarian and vegan medical nutrition alternatives. This demand pushes producers to create new products utilizing plant-based micronutrients and alternative proteins, making specialized nutrition more accessible to a wider variety of patients. Nestle S.A. demonstrated its commitment to this trend in March 2026 by launching Compleat Paediatric Oral Blends, a fruit-based medical nutrition line enriched with plant proteins that was first introduced in multiple European nations, perfectly illustrating the sector's adaptation to the growing desire for plant-derived clinical nutrition.

Key Market Players

  • Abbott Laboratories
  • Nestle Health Science
  • Danone S.A.
  • Fresenius Kabi AG
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Pfizer Inc.
  • Perrigo Company plc
  • Mead Johnson Nutrition Company
  • Hero Nutritionals Inc

Report Scope

In this report, the Global Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Nutrition Market, By Route of Administration

  • Oral
  • Intravenous

Clinical Nutrition Market, By Nutrition Type

  • Enteral Nutrition
  • Parental Nutrition

Clinical Nutrition Market, By Application

  • Metabolic Disorders
  • Eating Disorders
  • Stages of Development and Recovery
  • Others

Clinical Nutrition Market, By End User

  • Infant & Child
  • Adults
  • Geriatrics

Clinical Nutrition Market, By Substrates

  • Energy
  • Carbohydrates
  • Lipids
  • Proteins & amino acids
  • Water & electrolyte
  • Dietary fiber
  • Antioxidants

Clinical Nutrition Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Nutrition Market.

Available Customizations:

Global Clinical Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Route of Administration (Oral, Intravenous)
    • 5.2.2. By Nutrition Type (Enteral Nutrition, Parental Nutrition)
    • 5.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
    • 5.2.4. By End User (Infant & Child, Adults, Geriatrics)
    • 5.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Clinical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Route of Administration
    • 6.2.2. By Nutrition Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Substrates
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Route of Administration
        • 6.3.1.2.2. By Nutrition Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
        • 6.3.1.2.5. By Substrates
    • 6.3.2. Canada Clinical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Route of Administration
        • 6.3.2.2.2. By Nutrition Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
        • 6.3.2.2.5. By Substrates
    • 6.3.3. Mexico Clinical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Route of Administration
        • 6.3.3.2.2. By Nutrition Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User
        • 6.3.3.2.5. By Substrates

7. Europe Clinical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Route of Administration
    • 7.2.2. By Nutrition Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Substrates
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Clinical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Route of Administration
        • 7.3.1.2.2. By Nutrition Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
        • 7.3.1.2.5. By Substrates
    • 7.3.2. France Clinical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Route of Administration
        • 7.3.2.2.2. By Nutrition Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
        • 7.3.2.2.5. By Substrates
    • 7.3.3. United Kingdom Clinical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Route of Administration
        • 7.3.3.2.2. By Nutrition Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
        • 7.3.3.2.5. By Substrates
    • 7.3.4. Italy Clinical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Route of Administration
        • 7.3.4.2.2. By Nutrition Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
        • 7.3.4.2.5. By Substrates
    • 7.3.5. Spain Clinical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Route of Administration
        • 7.3.5.2.2. By Nutrition Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User
        • 7.3.5.2.5. By Substrates

8. Asia Pacific Clinical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Route of Administration
    • 8.2.2. By Nutrition Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Substrates
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Clinical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Route of Administration
        • 8.3.1.2.2. By Nutrition Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
        • 8.3.1.2.5. By Substrates
    • 8.3.2. India Clinical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Route of Administration
        • 8.3.2.2.2. By Nutrition Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
        • 8.3.2.2.5. By Substrates
    • 8.3.3. Japan Clinical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Route of Administration
        • 8.3.3.2.2. By Nutrition Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
        • 8.3.3.2.5. By Substrates
    • 8.3.4. South Korea Clinical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Route of Administration
        • 8.3.4.2.2. By Nutrition Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
        • 8.3.4.2.5. By Substrates
    • 8.3.5. Australia Clinical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Route of Administration
        • 8.3.5.2.2. By Nutrition Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User
        • 8.3.5.2.5. By Substrates

9. Middle East & Africa Clinical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Route of Administration
    • 9.2.2. By Nutrition Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Substrates
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Clinical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Route of Administration
        • 9.3.1.2.2. By Nutrition Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
        • 9.3.1.2.5. By Substrates
    • 9.3.2. UAE Clinical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Route of Administration
        • 9.3.2.2.2. By Nutrition Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
        • 9.3.2.2.5. By Substrates
    • 9.3.3. South Africa Clinical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Route of Administration
        • 9.3.3.2.2. By Nutrition Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
        • 9.3.3.2.5. By Substrates

10. South America Clinical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Route of Administration
    • 10.2.2. By Nutrition Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Substrates
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Route of Administration
        • 10.3.1.2.2. By Nutrition Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
        • 10.3.1.2.5. By Substrates
    • 10.3.2. Colombia Clinical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Route of Administration
        • 10.3.2.2.2. By Nutrition Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
        • 10.3.2.2.5. By Substrates
    • 10.3.3. Argentina Clinical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Route of Administration
        • 10.3.3.2.2. By Nutrition Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User
        • 10.3.3.2.5. By Substrates

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Nestle Health Science
  • 15.3. Danone S.A.
  • 15.4. Fresenius Kabi AG
  • 15.5. Baxter International Inc.
  • 15.6. B. Braun Melsungen AG
  • 15.7. Pfizer Inc.
  • 15.8. Perrigo Company plc
  • 15.9. Mead Johnson Nutrition Company
  • 15.10. Hero Nutritionals Inc

16. Strategic Recommendations

17. About Us & Disclaimer